No major new litigation or adverse regulatory findings by June 2027
Resolves: No new material adverse regulatory findings or mass-tort settlements exceeding $1B are disclosed in the Q4 10-K filing.
sec_filing· Regulatory/Legal
No major new litigation or adverse regulatory findings by June 2027
Market overview
Derived from JOHNSON & JOHNSON (JNJ) (CIK 0000200406) 10-Q filing analysis
Regulatory/Legal prediction market
- Implied probability (Yes)
- 75%
- Closes
About this prediction
Resolution criteria
No new material adverse regulatory findings or mass-tort settlements exceeding $1B are disclosed in the Q4 10-K filing.
More Regulatory/Legal markets
- Antitrust and regulatory approval of acquisition — 10% Yes
- Will Karbon-X receive major international registry certification by EOY 2027? — 55% Yes
- Absence of new regulatory or legal actions — 30% Yes
- Will COF reach a major regulatory settlement by mid-2027? — 40% Yes
- Major EPA Regulation Impacting Pressure Pumping by mid-2027 — 30% Yes
- Will Navient resolve a major outstanding legacy legal case by year-end 2027? — 55% Yes
- TCBX terminates the current share repurchase program within 12 months — 15% Yes
- Will PM receive key regulatory approval for new smoke-free production by mid-2027? — 60% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…